These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 33735876)

  • 1. Biological Therapies for Atopic Dermatitis: A Systematic Review.
    Zhou S; Qi F; Gong Y; Zhang J; Zhu B
    Dermatology; 2021; 237(4):542-552. PubMed ID: 33735876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.
    Edwards SJ; Karner C; Jhita T; Barton S; Marceniuk G; Yiu ZZN; Wittmann M
    Health Technol Assess; 2024 Jan; 28(4):1-113. PubMed ID: 38343072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current and upcoming treatments of adult atopic dermatitis].
    Lacour JP
    Ann Dermatol Venereol; 2017 Dec; 144 Suppl 5():VS29-VS37. PubMed ID: 29433635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Biologics Efficacious in Atopic Dermatitis? A Systematic Review and Meta-Analysis.
    Snast I; Reiter O; Hodak E; Friedland R; Mimouni D; Leshem YA
    Am J Clin Dermatol; 2018 Apr; 19(2):145-165. PubMed ID: 29098604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas.
    Kołkowski K; Trzeciak M; Sokołowska-Wojdyło M
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Janus kinase inhibitors for atopic dermatitis: a promising treatment modality.
    Cartron AM; Nguyen TH; Roh YS; Kwatra MM; Kwatra SG
    Clin Exp Dermatol; 2021 Jul; 46(5):820-824. PubMed ID: 33484582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Journal club: New small molecules for atopic dermatitis management.
    Lefevre MA; Mohme S; Alband N; Nogueira M; Rosell Diaz A; Rodriguez-Lomba E
    Eur J Dermatol; 2021 Dec; 31(6):849-852. PubMed ID: 35107077
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel systemic drugs in treatment of atopic dermatitis: results from phase II and phase III studies published in 2017/2018.
    Werfel T
    Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):432-437. PubMed ID: 30095475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Janus Kinase Inhibitors in Pediatric Atopic Dermatitis.
    Navarrete-Rodríguez EM; Larenas-Linnemann D; Vidaurri de la Cruz H; Luna-Pech JA; Guevara Sanginés E
    Curr Allergy Asthma Rep; 2024 Sep; 24(9):485-496. PubMed ID: 39105881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel topical and systemic therapies in atopic dermatitis.
    Suga H; Sato S
    Immunol Med; 2019 Jun; 42(2):84-93. PubMed ID: 31318324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK inhibitors in dermatology: The promise of a new drug class.
    Damsky W; King BA
    J Am Acad Dermatol; 2017 Apr; 76(4):736-744. PubMed ID: 28139263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Not Available].
    Lacour JP
    Ann Dermatol Venereol; 2019 Dec; 146(12S3):12S76-12S84. PubMed ID: 31997736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New and emerging targeted systemic therapies: a new era for atopic dermatitis.
    Lee DE; Clark AK; Tran KA; Shi VY
    J Dermatolog Treat; 2018 Jun; 29(4):364-374. PubMed ID: 28853956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral small molecules for the treatment of atopic dermatitis: a systematic review.
    Mobasher P; Heydari Seradj M; Raffi J; Juhasz M; Atanaskova Mesinkovska N
    J Dermatolog Treat; 2019 Sep; 30(6):550-557. PubMed ID: 30501539
    [No Abstract]   [Full Text] [Related]  

  • 15. Switching from baricitinib to dupilumab as an advanced-line treatment in pediatric patients with atopic dermatitis: a retrospective cohort study.
    Ollech A; Cohen-Barak E; Horev A; Bar-Ilan E; Greenberger S
    Int J Dermatol; 2024 Jul; 63(7):e130-e132. PubMed ID: 38751334
    [No Abstract]   [Full Text] [Related]  

  • 16. Janus kinase inhibitors in dermatology: A systematic review.
    Shreberk-Hassidim R; Ramot Y; Zlotogorski A
    J Am Acad Dermatol; 2017 Apr; 76(4):745-753.e19. PubMed ID: 28169015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatments for Childhood Atopic Dermatitis: an Update on Emerging Therapies.
    Chu CY
    Clin Rev Allergy Immunol; 2021 Oct; 61(2):114-127. PubMed ID: 32607924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab: A review of its use in the treatment of atopic dermatitis.
    Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate-to-severe atopic dermatitis: A network meta-analysis.
    Wan H; Jia H; Xia T; Zhang D
    Dermatol Ther; 2022 Sep; 35(9):e15636. PubMed ID: 35703351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute spondyloarthritis developing during successful treatment with dupilumab for severe atopic dermatitis.
    Raimondo A; Guglielmi G; Marino C; Ligrone L; Lembo S
    Clin Exp Dermatol; 2022 Mar; 47(3):592-593. PubMed ID: 34655234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 41.